-
Dominant McKibbin wins Hong Kong Open to seal Masters spot
-
US Navy veterans battle PTSD with psychedelics
-
'Unheard of': Dodgers in awe of iron man Yamamoto
-
UK police probe mass train stabbing that wounded 10
-
'It's hard' - Jays manager Schneider rues missed chances in World Series defeat
-
Women's cricket set for new champion as India, South Africa clash
-
Messi scores but Miami lose as Nashville level MLS Cup playoff series
-
Dodgers clinch back-to-back World Series as Blue Jays downed in thriller
-
Vietnam flood death toll rises to 35: disaster agency
-
History-making Japan golf twins push each other to greater heights
-
Death becomes a growing business in ageing, lonely South Korea
-
India's cloud seeding trials 'costly spectacle'
-
Chiba wins women's title, Malinin leads at Skate Canada
-
Siakam sparks injury-hit Pacers to season's first NBA win
-
Denmark's fabled restaurant noma sells products to amateur cooks
-
UK train stabbing wounds 10, two suspects arrested
-
Nashville top Messi's Miami 2-1 to level MLS Cup playoff series
-
Fergie, her daughters and the corgis hit by Andrew crisis
-
'I can't eat': Millions risk losing food aid during US shutdown
-
High price of gold inspires new rush in California
-
'Swing for the fences': Carney promises bold budget as US threat grows
-
UK police arrest two after 'multiple people' stabbed on train
-
NBA Hawks lose guard Young for four weeks with knee sprain
-
50 dead as Caribbean digs out from Hurricane Melissa
-
Forever Young gives Japan first Breeders' Cup Classic triumph
-
Mbappe's Real Madrid extend Liga lead, Villarreal move second
-
Salah savours 'great feeling' after 250th Liverpool goal
-
Ethical Diamond surges to upset win in $5 million Breeders' Cup Turf
-
Kinghorn kicks Toulouse to Top 14 summit
-
Mbappe extends Real Madrid's Liga lead in Valencia rout
-
All Blacks sink 14-man Ireland 26-13 in Chicago Test
-
World champ Malinin takes lead at Skate Canada
-
Liverpool snap losing streak as Salah hits 250 goals in Villa win
-
Salah's 250th Liverpool goal sinks Villa as Arsenal cruise at Burnley
-
Morant suspended by Grizzlies after rebuking coaching staff
-
Spalletti begins Juve tenure with win at Cremonese but Napoli held
-
Frank refuses to condemn Van de Ven, Spence for snub in Spurs defeat
-
France superstar Dupont extends Toulouse deal
-
Egypt officially opens grand museum near pyramids
-
French fraud watchdog reports Shein for 'childlike' sex dolls
-
Scotland thrash USA before All Blacks' clash
-
Five things to know about the Grand Egyptian Museum
-
Bayern rest stars but ease past Leverkusen before PSG clash
-
Dead quiet: Paris Catacombs close for renovations
-
Families separated, children killed as survivors flee Sudan's 'apocalyptic' El-Fasher
-
Napoli held by Como as Spalletti begins Juve adventure
-
Southampton boss Still vows to fight on as pressure mounts
-
Borthwick hails 'ball of energy' Pollock as England down Australia
-
Egypt opens grand museum in lavish, pharaonic ceremony
-
Joao Pedro strikes at last as Chelsea edge past Spurs
Who should get paid for nature's sequenced genes?
Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.
The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.
Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.
"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.
"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.
Much of the information comes from poor countries.
Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.
At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).
Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?
- 'Cheap and very fast' -
The issue is a complex one.
There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.
But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?
"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.
These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.
DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.
"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.
"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.
- Mandatory -
A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.
They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.
"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.
Another sticking point is access for Indigenous people and local communities to DSI funds.
Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.
But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.
With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.
The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.
Added Barber: "I think it's not going to all get solved here."
J.Oliveira--AMWN